For instance, mRNA and protein levels of C/EBPβ are increased in AD patients’ brains [26,27] and in amyotrophic lateral sclerosis (ALS) spinal cord samples [28,29]; however, little is known regarding C/EBPβ implication on PD pathology. This evidence concerns the gene CEBPB and Parkinson disease.